论文部分内容阅读
目的 :探讨为脑梗死患者应用血管扩张剂进行治疗的临床疗效及安全性。方法 :将2012年9月至2014年1月我院收治的103例脑梗死患者随机分为对照组和研究组,为53例对照组患者进行常规治疗,为50例研究组患者在进行常规治疗的基础上加用血管扩张剂进行治疗,并对比分析其临床疗效。结果 :研究组患者治疗的总有效率为96.0%,对照组患者治疗的总有效率为69.8%,研究组患者治疗的总有效率明显高于对照组患者,差异显著(P<0.05),有统计学意义。研究组患者不良反应的发生率为4.0%,对照组患者不良反应的发生率为5.6%,二者相比差异不显著(P>0.05),无统计学意义。结论 :为脑梗死患者应用血管扩张剂进行治疗可显著提高其临床疗效,改善其神经功能缺损的情况,而且安全性较高,此法值得在临床上推广应用。
Objective: To investigate the clinical efficacy and safety of vasodilator in patients with cerebral infarction. Methods: From September 2012 to January 2014, 103 patients with cerebral infarction admitted to our hospital were randomly divided into control group and study group. 53 patients in control group were treated routinely, and 50 patients in study group received routine treatment Based on the use of vasodilators for treatment, and comparative analysis of its clinical efficacy. Results: The total effective rate of study group was 96.0%, while that of control group was 69.8%. The total effective rate of study group was significantly higher than that of control group (P <0.05) Statistical significance. In the study group, the incidence of adverse reactions was 4.0% and that of the control group was 5.6%. There was no significant difference between the two groups (P> 0.05). There was no statistical significance. Conclusion: The application of vasodilator in patients with cerebral infarction can significantly improve the clinical efficacy and improve the neurological deficit, and the safety is high. This method is worthy of clinical application.